Hippo signaling inhibition in AD mice
收藏官方服务：
资源简介：
Western blot images
应用场景：
创建时间：
2025-02-01
相关数据集
Gender differences contribute to variability of serum lipid biomarkers for Alzheimer’s disease - Supplemental Table 4
Background: Alzheimer’s disease (AD) cannot currently be diagnosed by a blood test. One reason may be gender differences. Another may be the statistical methods used. The authors evaluate these possib
DataCite Commons2024-05-17 更新140
Sundown syndrome in patients with Alzheimer’s disease dementia
ABSTRACT The sundown syndrome is a complex neurobehavioral disorder in patients with dementia associated with high financial cost and significant caregiver burden. It is a multifactorial phenomenon wi
DataCite Commons2021-03-25 更新70
Additional file 4 of Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease
Additional file 4: Table S3. The layer-specific markers found from our human postmortem Visium SRT dataset and the previously known layer markers.
DataCite Commons2024-02-07 更新60
Candidate CSF biomarkers reflect AD-related pathophysiologic changes.
CSF biomarkers are grouped according to reported function(s) and, when appropriate, cellular locations. Asterisks (*) indicate those biomarkers found to be increased in AD CSF; the vast majority were
NIAID Data Ecosystem110
Data_Sheet_1_Targeting MicroRNA-125b Promotes Neurite Outgrowth but Represses Cell Apoptosis and Inflammation via Blocking PTGS2 and CDK5 in a FOXQ1-Dependent Way in Alzheimer Disease.pdf
This study aimed to explore the molecular regulatory network among microRNA-125b (miR-125b), forkhead box Q1 (FOXQ1), prostaglandin-endoperoxide synthase 2 (PTGS2), and cyclin-dependent kinase 5 (CDK5
NIAID Data Ecosystem60
